Drugs / Leuprorelin SR
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01122121 | Mar 2000 → Dec 2008 | prostate cancer | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Leuprorelin SR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01122121 ↗ |
| Route | Subcutaneous | “injection, subcutaneously” NCT01122121 ↗ |